Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naive anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option.
Ontology highlight
SUBMITTER: Ricciuti B
PROVIDER: S-EPMC6987338 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA